Abstract | BACKGROUND/AIMS: Adhesion-regulating molecule 1 (ADRM1), a receptor located on the 26S proteasome, is upregulated in many solid cancers. However, little is known about its role in acute leukemia (AL). METHODS: We determined ADRM1 expression levels in both untreated AL samples and leukemia cell lines using real-time polymerase chain reaction or Western blot analysis. Growth curves, colony formation assays, cell cycle and apoptosis analyses, cell migration and invasion assays and NF-κB p65 nuclear translocation assays via Western blotting were used to examine the biological behavior of HL60 cells and the underlying mechanism. RESULTS: ADRM1 was upregulated in both untreated AL samples and leukemia cell lines. ADRM1 knockdown significantly suppressed HL60 cell proliferation (48.82 ± 12.58%) and colony formation and caused cell cycle arrest in the G0/G1 phase. Furthermore, we confirmed that ADRM1 knockdown suppressed p65 nuclear translocation. CONCLUSION: Our study revealed that ADRM1 was overexpressed in AL, especially in CD34+ leukemia stem and progenitor cells. ADRM1 may play a role in AL via the proteasome- ubiquitin pathway by potentially sustaining the activation of NF-κB signaling.
|
Authors | Xiaohui Zheng, Yafei Guo, Yingying Chen, Meilin Chen, Zhenxin Lin, Yong Wu, Yuanzhong Chen |
Journal | Acta haematologica
(Acta Haematol)
Vol. 134
Issue 2
Pg. 88-100
( 2015)
ISSN: 1421-9662 [Electronic] Switzerland |
PMID | 25896055
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2015 S. Karger AG, Basel. |
Chemical References |
- ADRM1 protein, human
- Antigens, CD34
- Intracellular Signaling Peptides and Proteins
- Membrane Glycoproteins
- Neoplasm Proteins
- RNA, Small Interfering
|
Topics |
- Antigens, CD34
(metabolism)
- Apoptosis
- Cell Line, Tumor
- Cell Movement
- Cell Proliferation
- G1 Phase
- Gene Expression Regulation, Neoplastic
- Gene Knockdown Techniques
- HL-60 Cells
- Humans
- Intracellular Signaling Peptides and Proteins
- Leukemia
(blood, metabolism, pathology, therapy)
- Leukemia, Promyelocytic, Acute
(blood, metabolism, pathology, therapy)
- Leukocytes, Mononuclear
(metabolism, pathology)
- Membrane Glycoproteins
(antagonists & inhibitors, genetics, metabolism)
- Neoplasm Proteins
(antagonists & inhibitors, genetics, metabolism)
- RNA Interference
- RNA, Small Interfering
- Resting Phase, Cell Cycle
- Tumor Cells, Cultured
- Tumor Stem Cell Assay
|